• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Nasdaq Gains Over 50 Points; US Durable Goods Orders Rise In February

    3/26/24 10:09:37 AM ET
    $APCX
    $CISS
    $NBSE
    $OPGN
    Computer Software: Prepackaged Software
    Technology
    Marine Transportation
    Consumer Discretionary
    Get the next $APCX alert in real time by email

    U.S. stocks traded higher this morning, with the Nasdaq Composite gaining over 50 points on Tuesday.

    The Dow traded up 0.08% to 39,346.40 while the NASDAQ rose 0.39% to 16,448.92. The S&P 500 also fell, dropping, 0.23% to 5,230.19.

    Check This Out: Top 3 Energy Stocks That May Keep You Up At Night In Q1

     

    Leading and Lagging Sectors

     

    Consumer discretionary shares jumped by 0.7% on Monday.

    In trading on Monday, energy shares fell by 0.2%.

     

    Top Headline

     

    U.S. durable goods orders increased by 1.4% month-over-month in February versus a revised 6.9% decline in January.

     

    Equities Trading UP

     

    Stoke Therapeutics, Inc. (NASDAQ:STOK) shares shot up 74% to $11.31 after the company announced Phase 1/2a data supporting the potential for STK-001 in Dravet syndrome.

    Shares of C3is Inc. (NASDAQ:CISS) got a boost, surging 67% to $0.0587 after the company reported a year-over-year increase in fourth-quarter financial results.

    OpGen, Inc. (NASDAQ:OPGN) shares were also up, gaining 48% to $0.7021 after the company entered into a securities purchase agreement with a private investor, David Lazar, to acquire 3 million shares of Series E Convertible Preferred Stock at $1.00 per share for aggregate gross proceeds of $3.0 million.

     

    Equities Trading DOWN

     

    NeuBase Therapeutics, Inc. (NASDAQ:NBSE) shares dropped 48% to $0.5152 after declining around 3% on Monday.

    Shares of Quhuo Limited (NASDAQ:QH) were down 46% to $0.68.

    AppTech Payments Corp. (NASDAQ:APCX) was down, falling 40% to $0.99 after the company priced its 2 million share offering at $1 per share.

    Also Check This Out: Wall Street's Most Accurate Analysts Say Buy These 3 Energy Stocks With Over 5% Dividend Yields

     

    Commodities

     

    In commodity news, oil traded up 1.7% to $81.98 while gold traded up 0.9% at $ 2,196.70.

    Silver traded up 0.4% to $24.98 on Monday, while copper fell 0.1% to $4.0145.

     

    Euro zone

     

    European shares were higher today. The eurozone’s STOXX 600 rose 0.2%, London’s FTSE 100 rose 0.1% while Spain’s IBEX 35 Index rose 0.3% The German DAX rose 0.7% French CAC 40 rose 0.2% while Italy’s FTSE MIB Index rose 0.3%.

    The GfK Consumer Climate Indicator for Germany rose to -27.4 heading into April compared to a revised reading of -28.8 in the prior period. Spanish economy grew 0.6% in the fourth quarter, compared to a 0.4% increase in the prior period.

     

    Asia Pacific Markets

     

    Asian markets closed mixed on Tuesday, with Japan’s Nikkei 225 falling 0.04%, Hong Kong’s Hang Seng Index gaining 0.88%, China’s Shanghai Composite Index gaining 0.17% and India’s S&P BSE Sensex falling 0.50%.

    Hong Kong’s trade deficit narrowed to $41.7 billion in February versus a $45.4 billion gap recorded in the year-ago period.

     

    Economics

     

    U.S. durable goods orders increased by 1.4% month-over-month in February versus a revised 6.9% decline in January.

    The S&P CoreLogic Case-Shiller 20-city home price index increased by 6.6% year-over-year in January compared to a 6.2% gain in the prior month.

    The FHFA house price index fell by 0.1% in January.

    Now Read This: How To Earn $500 A Month From Micron Technology Stock After Last Week's Strong Earnings

    Get the next $APCX alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $APCX
    $CISS
    $NBSE
    $OPGN

    CompanyDatePrice TargetRatingAnalyst
    Stoke Therapeutics Inc.
    $STOK
    2/24/2026$40.00Outperform
    Wolfe Research
    Stoke Therapeutics Inc.
    $STOK
    2/5/2026$60.00Buy
    Guggenheim
    Stoke Therapeutics Inc.
    $STOK
    1/5/2026$35.00Buy
    Chardan Capital Markets
    Stoke Therapeutics Inc.
    $STOK
    7/18/2025$30.00Buy
    Jefferies
    Stoke Therapeutics Inc.
    $STOK
    12/20/2024$24.00Buy
    Chardan Capital Markets
    Stoke Therapeutics Inc.
    $STOK
    10/14/2024$18.00Outperform
    Leerink Partners
    Stoke Therapeutics Inc.
    $STOK
    3/26/2024Market Perform → Outperform
    TD Cowen
    Stoke Therapeutics Inc.
    $STOK
    11/20/2023Neutral
    JP Morgan
    More analyst ratings

    $APCX
    $CISS
    $NBSE
    $OPGN
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Chief Executive Officer Derosa Thomas Joseph bought $3,299 worth of shares (10,000 units at $0.33), increasing direct ownership by 22% to 56,096 units (SEC Form 4)

    4 - AppTech Payments Corp. (0001070050) (Issuer)

    3/5/26 4:58:08 PM ET
    $APCX
    Computer Software: Prepackaged Software
    Technology

    Director Lord Albert L bought $9,578 worth of shares (29,606 units at $0.32), increasing direct ownership by 0.91% to 3,300,000 units (SEC Form 4)

    4 - AppTech Payments Corp. (0001070050) (Issuer)

    3/5/26 4:57:43 PM ET
    $APCX
    Computer Software: Prepackaged Software
    Technology

    Director Lord Albert L bought $31,350 worth of shares (100,000 units at $0.31), increasing direct ownership by 3% to 3,270,394 units (SEC Form 4)

    4 - AppTech Payments Corp. (0001070050) (Issuer)

    3/3/26 6:23:42 PM ET
    $APCX
    Computer Software: Prepackaged Software
    Technology

    $APCX
    $CISS
    $NBSE
    $OPGN
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Wolfe Research initiated coverage on Stoke Therapeutics with a new price target

    Wolfe Research initiated coverage of Stoke Therapeutics with a rating of Outperform and set a new price target of $40.00

    2/24/26 7:56:29 AM ET
    $STOK
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Guggenheim initiated coverage on Stoke Therapeutics with a new price target

    Guggenheim initiated coverage of Stoke Therapeutics with a rating of Buy and set a new price target of $60.00

    2/5/26 6:58:02 AM ET
    $STOK
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Chardan Capital Markets resumed coverage on Stoke Therapeutics with a new price target

    Chardan Capital Markets resumed coverage of Stoke Therapeutics with a rating of Buy and set a new price target of $35.00

    1/5/26 9:19:09 AM ET
    $STOK
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $APCX
    $CISS
    $NBSE
    $OPGN
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    C3is Inc. Announces Reverse Stock Split

    To be effective April 27, 2026 Aiming to meet the minimum bid price requirement for maintaining listing on Nasdaq ATHENS, Greece, April 23, 2026 (GLOBE NEWSWIRE) -- C3is Inc. (the "Company") (NASDAQ:CISS) today announced that its board of directors has determined to effect a one-for-seven (1-for-7) reverse stock split of the Company's common stock, par value $0.01 per share. The reverse stock split will take effect at 11:59 pm Eastern Time on April 26, 2026, and the Company's common stock will begin trading on a split-adjusted basis on The Nasdaq Capital Market ("Nasdaq") as of the opening of trading on April 27, 2026. The CUSIP number of Y18284300 will be assigned to the Company's com

    4/23/26 8:30:00 AM ET
    $CISS
    Marine Transportation
    Consumer Discretionary

    Stoke Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)

    Stoke Therapeutics, Inc. (NASDAQ:STOK) is a biotechnology company dedicated to restoring protein expression by harnessing the body's potential with RNA medicine and has a lead investigational medicine, zorevunersen, in development as a first-in-class potential disease-modifying treatment for Dravet syndrome. The Company today announced that, effective on April 15, 2026, it granted stock options to purchase an aggregate of 129,565 shares of common stock to fourteen new employees, as a material inducement to their employment in accordance with Nasdaq Listing Rule 5635(c)(4). The stock options that were granted have an exercise price of $35.54 per share, which is equal to the closing price o

    4/16/26 4:01:00 PM ET
    $STOK
    Biotechnology: Pharmaceutical Preparations
    Health Care

    AppTech Payments Corp. Reports Q1 Operating Results

    CARLSBAD, Calif., April 16, 2026 (GLOBE NEWSWIRE) -- AppTech Payments Corp. ("AppTech" or the "Company") (OTCQB:APCX), a fintech company, today announced financial results for the first quarter ended March 31, 2026. The Company today reported a GAAP operating loss of $2.7 million for the first quarter of 2026.  Operating losses in the first and fourth quarters of 2025 were $2.6 million and $1.3 million, respectively. To better understand the actual operating performance, management uses a modified cash-based measure that excludes non-cash expenses, principally equity-based compensation and amortization of intangible assets. On this basis, AppTech reported a loss of $0.6 million ($0.01 pe

    4/16/26 9:00:00 AM ET
    $APCX
    Computer Software: Prepackaged Software
    Technology

    $APCX
    $CISS
    $NBSE
    $OPGN
    SEC Filings

    View All

    SEC Form 6-K filed by C3is Inc.

    6-K - C3is Inc. (0001951067) (Filer)

    4/23/26 4:15:10 PM ET
    $CISS
    Marine Transportation
    Consumer Discretionary

    SEC Form 20-F filed by C3is Inc.

    20-F - C3is Inc. (0001951067) (Filer)

    4/22/26 4:15:56 PM ET
    $CISS
    Marine Transportation
    Consumer Discretionary

    SEC Form DEFA14A filed by Stoke Therapeutics Inc.

    DEFA14A - Stoke Therapeutics, Inc. (0001623526) (Filer)

    4/22/26 4:09:16 PM ET
    $STOK
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $APCX
    $CISS
    $NBSE
    $OPGN
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 4 filed by Kahn Clare

    4 - Stoke Therapeutics, Inc. (0001623526) (Issuer)

    4/7/26 7:09:14 PM ET
    $STOK
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEC Form 3 filed by new insider Kahn Clare

    3 - Stoke Therapeutics, Inc. (0001623526) (Issuer)

    4/7/26 7:08:13 PM ET
    $STOK
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEC Form 4 filed by Ticho Barry

    4 - Stoke Therapeutics, Inc. (0001623526) (Issuer)

    4/3/26 4:12:37 PM ET
    $STOK
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $APCX
    $CISS
    $NBSE
    $OPGN
    Financials

    Live finance-specific insights

    View All

    Quhuo Reports Financial Results for the Second Half and Full Year 2025

    BEIJING, April 2, 2026 /PRNewswire/ -- Quhuo Limited (NASDAQ:QH) ("Quhuo," the "Company," "we" or "our"), a leading gig economy platform focusing on local life services in China, today reported its unaudited financial results for the six months and full year ended December 31, 2025. Financial and Operational Highlights for the Second Half of 2025Revenues from housekeeping and accommodation solutions and other services were RMB45.7 million (US$6.5 million), representing a year-over-year increase of 99.8% from RMB22.9 million.Gross profit of vehicle export solutions was RMB12.6 million (US$1.8 million), representing a year-over-year increase of 327.9% from RMB2.9 million.Gross profit of housek

    4/2/26 4:10:00 PM ET
    $QH
    Real Estate

    C3is Inc. reports fourth quarter and twelve months 2025 financial and operating results

    ATHENS, Greece, Feb. 19, 2026 (GLOBE NEWSWIRE) -- C3is Inc. (NASDAQ:CISS) (the "Company"), a ship-owning company providing drybulk and tanker seaborne transportation services, announced today its unaudited financial and operating results for the fourth quarter and twelve months ended December 31, 2025. OPERATIONAL AND FINANCIAL HIGHLIGHTS Our handysize dry bulk carriers are on time charters of short-term durations, producing steady cash flows, while our Aframax tanker operates in the spot market, currently achieving voyage charter rates of around $60,000 per day.All of our vessels are unencumbered.Fleet operational utilization of 93.5% for the three months ended December 31, 2025, compar

    2/19/26 9:10:00 AM ET
    $CISS
    Marine Transportation
    Consumer Discretionary

    C3is Inc. reports fourth quarter and twelve months 2025 financial and operating results

    ATHENS, Greece, Feb. 19, 2026 (GLOBE NEWSWIRE) -- C3is Inc. (NASDAQ:CISS) (the "Company"), a ship-owning company providing drybulk and tanker seaborne transportation services, announced today its unaudited financial and operating results for the fourth quarter and twelve months ended December 31, 2025. OPERATIONAL AND FINANCIAL HIGHLIGHTS Our handysize dry bulk carriers are on time charters of short-term durations, producing steady cash flows, while our Aframax tanker operates in the spot market, currently achieving voyage charter rates of around $60,000 per day.All of our vessels are unencumbered.Fleet operational utilization of 93.5% for the three months ended December 31, 2025, compar

    2/19/26 9:10:00 AM ET
    $CISS
    Marine Transportation
    Consumer Discretionary

    $APCX
    $CISS
    $NBSE
    $OPGN
    Leadership Updates

    Live Leadership Updates

    View All

    Stoke Therapeutics Appoints Clare Kahn, Ph.D., to its Board of Directors

    Stoke Therapeutics, Inc. (NASDAQ:STOK) is a biotechnology company dedicated to restoring protein expression by harnessing the body's potential with RNA medicine and has a lead investigational medicine, zorevunersen, in development as a first-in-class potential disease-modifying treatment for Dravet syndrome. Today, the Company announced the appointment of Clare Kahn, Ph.D., to its Board of Directors. "Clare brings more than three decades of industry experience, and we are very pleased to welcome her to the Board at this pivotal time for Stoke," said Ian F. Smith, Chief Executive Officer and Director of Stoke Therapeutics. "Clare's deep regulatory strategy and drug development expertise, p

    4/7/26 4:01:00 PM ET
    $BIIB
    $STOK
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care
    Biotechnology: Pharmaceutical Preparations

    AppTech Payments Corp. CEO and CFO Changes

    CARLSBAD, Calif., Dec. 30, 2024 (GLOBE NEWSWIRE) -- AppTech Payments Corp. ("AppTech or the "Company") (NASDAQ:APCX) announced today that it has accepted the resignation of Luke D'Angelo, as the Company's Chief Executive Officer and Executive Director effective December 24, 2024. Mr. D'Angelo will continue his employment as Chairman of the Company's Board of Directors. The Company has appointed Thomas DeRosa to serve as Interim CEO. "As I step down from my CEO and Executive Director roles, I am filled with immense pride for all we've accomplished together. It has truly been an honor to lead this incredible Company, and I'm grateful to have had the opportunity to work alongside such a tale

    12/30/24 7:45:00 AM ET
    $APCX
    Computer Software: Prepackaged Software
    Technology

    AppTech Announces $5,000,000 Common Equity Raise and Board Member Changes

    Initial $5 million investment for common stock priced at an average of $0.96 per share; Up to an additional $14 million may be raised from exercise of warrants Albert L. Lord, Thomas J. Kozlowski Jr., and Calvin D. Walsh added to the Board of Directors CARLSBAD, Calif., Dec. 17, 2024 (GLOBE NEWSWIRE) -- AppTech Payments Corp. ("AppTech or the "Company") (NASDAQ:APCX) today announced that AFIOS Partners ("AFIOS"), an investment company including shareholders since 2015, today invested $5 million in the common stock of the Company. In connection with the transaction, the Company reduced its Board to five members from seven and appointed Albert L. Lord, Thomas J. Kozlowski Jr., and Calv

    12/17/24 7:30:00 AM ET
    $APCX
    Computer Software: Prepackaged Software
    Technology

    $APCX
    $CISS
    $NBSE
    $OPGN
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by Stoke Therapeutics Inc.

    SC 13G/A - Stoke Therapeutics, Inc. (0001623526) (Subject)

    11/14/24 9:00:58 PM ET
    $STOK
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEC Form SC 13G filed by Stoke Therapeutics Inc.

    SC 13G - Stoke Therapeutics, Inc. (0001623526) (Subject)

    11/14/24 4:24:49 PM ET
    $STOK
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Amendment: SEC Form SC 13G/A filed by Stoke Therapeutics Inc.

    SC 13G/A - Stoke Therapeutics, Inc. (0001623526) (Subject)

    11/14/24 9:00:12 AM ET
    $STOK
    Biotechnology: Pharmaceutical Preparations
    Health Care